Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low-and middle-income countries in Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue SUPPL.1, 2014, Pages

  Adebamowo, Clement A ^a   Casper, Corey ^b   Bhatia, Kishor ^c   Mbulaiteye, Sam M ^c   Sasco, Annie J ^d   Phipps, Warren ^b   Vermund, Sten H ^e   Krown, Susan E ^f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Africa; cancer diagnosis; cancer prevention; cancer screening; cancer therapy; developing countries; health workforce; HIV AIDS; infrastructure; low and middle income countries; research; training

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CANCER THERAPY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FINANCIAL MANAGEMENT; FUNDING; HIV ASSOCIATED CANCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCOME; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; MALARIA; MIXED INFECTION; NEOPLASM; PATHOGENESIS; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; TUBERCULOSIS; UTERINE CERVIX CANCER;

AFRICA; BIOMEDICAL RESEARCH; DELIVERY OF HEALTH CARE, INTEGRATED; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; EDUCATION, MEDICAL; HIV INFECTIONS; HUMANS; NEOPLASMS;

EID: 84906070936     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000255     Document Type: Article

References (92)

1. Hymes KB, Cheung T, Greene JB, et al. Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet. 1981;2:598-600
2. Centers for Disease Control. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy-United States. MMWR Morb Mortal Wkly Rep. 1991;40:591, 597-600.
3. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
4. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep. 1986;35:334-339.
5. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cancer in Africa: Epidemiology and Prevention. Lyon, France: IARC Press; 2003.
6. Parkin DM, Sitas F, Chirenje M, et al. Part I: cancer in indigenous Africans-burden, distribution, and trends. Lancet Oncol. 2008;9: 683-692.
7. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103: 753-762.
8. Casper C. The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med. 2011;62:157-170.
9. Goosby E, Dybul M, Fauci AS, et al. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic. J Acquir Immune Defic Syndr. 2012;60(suppl 3):S51-S56.
10. El-Sadr WM, Holmes CB, Mugyenyi P, et al. Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr. 2012;60(suppl 3):S96-S104.
11. April MD, Wood R, Berkowitz BK, et al. The survival benefits of antiretroviral therapy in South Africa. J Infect Dis. 2014;209:491-499.
12. Vermund SH. Massive benefits of antiretroviral therapy in Africa. J Infect Dis. 2014;209:483-485.
13. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860.
14. Chokunonga E, Levy LM, Bassett MT, et al. Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS. 1999;13:2583-2588.
15. Adebamowo CA, Akarolo-Anthony S. Cancer in Africa: opportunities for collaborative research and training. Afr J Med Med Sci. 2009;38 (suppl 2):5-13.
16. Bender E. Putting the brakes on cancer in Africa. Cancer Discov. 2013;3:8.
17. Hontelez JAC, Lurie MN, Newell M-L, et al. Ageing with HIV in South Africa. AIDS. 2011;25:1665-1667.
18. Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380:2144-2162.
19. Greig J, Casas EC, O'Brien DP, et al. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries. AIDS. 2012;26(suppl 1): S31-S37.
20. Boyle P, Levin B. World Cancer Report. Geneva, Switzerland: International Agency for Research on Cancer; 2008.
21. Ononogbu U, Almujtaba M, Modibbo F, et al. Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health. 2013;13:582.
22. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, et al. Utilization of cervical cancer screening services and trends in screening positivity rates in a "screen-and-treat" program integrated with HIV/AIDS care in Zambia. PLoS One. 2013;8:e74607.
23. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, et al. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther. 2010;4: 713-722.
24. Jedy-Agba E, Adebamowo C. Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in Nigeria. Infect Agent Cancer. 2012;7:28.
25. Dhir AA, Sawant S, Dikshit RP, et al. Spectrum of HIV/AIDS related cancers in India. Cancer Causes Control. 2008;19:147-153.
26. Tanon A, Jaquet A, Ekouevi DK, et al. The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One. 2012;7:e48108.
27. Biggar RJ, Chaturvedi AK, Bhatia K, et al. Cancer risk in persons with HIV/AIDS in India: a review and future directions for research. Infect Agent Cancer. 2009;4:4.
28. Zhang YX, Gui XE, Zhong YH, et al. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol. 2011;137:609-614.
29. Petoumenos K, Hui E, Kumarasamy N, et al. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc. 2010;13:51.
30. Wild CP. Aflatoxin exposure in developing countries: the critical interface of agriculture and health. Food Nutr Bull. 2007;28(suppl 2):S372-S380.
31. Nagaiah G, Stotler C, Orem J, et al. Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol. 2010;22:437-442.
32. Tiong T, Borooah S, Msosa J, et al. Clinicopathological review of ocular surface squamous neoplasia in Malawi. Br J Ophthalmol. 2013;97:961-964.
33. Pradeep TG, Gangasagara SB, Subbaramaiah GB, et al. Prevalence of undiagnosed HIV infection in patients with ocular surface squamous neoplasia in a tertiary center in Karnataka, South India. Cornea. 2012; 31:1282-1284.
34. Winstone TA, Man SF, Hull M, et al. Epidemic of lung cancer in patients with HIV infection. Chest. 2013;143:305-314.
35. Glynn T, Seffrin JR, Brawley OW, et al. The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin. 2010;60:50-61.
36. Ipp H, Zemlin AE, Erasmus RT, et al. Role of inflammation in HIV-1 disease progression and prognosis. Crit Rev Clin Lab Sci. 2014;51: 98-111.
37. Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis. 2010;10:455-463.
38. Orem J, Wabinga H. The roles of national cancer research institutions in evolving a comprehensive cancer control program in a developing country: experience from Uganda. Oncology. 2009;77:272-280.
39. Garfield DH, Brenner H, Lu L. Practicing western oncology in Shanghai, China: one group's experience. J Oncol Pract. 2013;9:e141-e144.
40. Lehmann K, Guller U, Bugnon S, et al. Interdisciplinary tumour boards in Switzerland: quo vadis? Swiss Med Wkly. 2008;138: 123-127.
41. Maree JE, Langley G, Nqubezelo L. "Not a nice experience, not at all": underprivileged women's experiences of being confronted with cervical cancer. Palliat Support Care. 2014:1-9. [epub ahead of print, February 13, 2014].
42. Maranga IO, Hampson L, Oliver AW, et al. Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS One. 2013;8:e78411.
43. Suneja G, Ramogola-Masire D, Medhin HG, et al. Cancer in Botswana: resources and opportunities. Lancet Oncol. 2013;14:e290-291.
44. Stefan DC, Elzawawy AM, Khaled HM, et al. Developing cancer control plans in Africa: examples from five countries. Lancet Oncol. 2013;14: e189-195.
45. Kingham TP, Alatise OI, Vanderpuye V, et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14:e158-167.
46. Gouws L, Eedes D, Marais E, et al. Revolutionising cancer care in South Africa. Lancet Oncol. 2012;13:447-448.
47. Hadley LG, Rouma BS, Saad-Eldin Y. Challenge of pediatric oncology in Africa. Semin Pediatr Surg. 2012;21:136-141.
48. Burki TK. Recent developments for cancer care in Africa. Lancet Oncol. 2012;13:e6.
49. Strother RM, Rao KV, Gregory KM, et al. The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya. J Oncol Pharm Pract. 2012;18:406-416.
50. Ugwumba FO, Aghaji AE. Testicular cancer: management challenges in an African developing country. S Afr Med J. 2010;100:452-455.
51. Yusuf AJ, Adamu A, Nuhu FT. Caregiver burden among poor caregivers of patients with cancer in an urban African setting. Psychooncology. 2011;20:902-905.
52. Sitas F, Parkin DM, Chirenje M, et al. Part II: cancer in indigenous Africans-causes and control. Lancet Oncol. 2008;9:786-795.
53. Dye TD, Bogale S, Hobden C, et al. Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Cancer. 2010; 116:577-585.
54. Ogwang MD, Zhao W, Ayers LW, et al. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med. 2011;135:445-450.
55. Adesina A, Chumba D, Nelson AM, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14:e152-157.
56. Orem J, Sandin S, Weibull CE, et al. Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol. 2012;4:339-347.
57. Adebamowo CA, Famooto A, Ogundiran TO, et al. Immunohistochem-ical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2008;110:183-188.
58. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6:603-612.
59. Adebamowo AC. The realities of providing cancer care in Nigeria. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 3, 2013; Chicago, IL.
60. Jedy-Agba E, Curado MP, Ogunbiyi O, et al. Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol. 2012;36:e271-e278.
61. Mbulaiteye SM, Talisuna AO, Ogwang MD, et al. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet. 2010;375:1661-1663.
62. Mbulaiteye SM, Bhatia K, Adebamowo C, et al. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer. 2011;6:16.
63. Lingwood RJ, Boyle P, Milburn A, et al. The challenge of cancer control in Africa. Nat Rev Cancer. 2008;8:398-403.
64. Adewole I, Martin DN, Williams MJ, et al. Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol. 2014;11:251-259.
65. Strother RM, Asirwa FC, Busakhala NB, et al. AMPATH-Oncology: a model for comprehensive cancer care in sub-Saharan Africa. J Cancer Policy. 2013;1:e42-e48.
66. Akarolo-Anthony SN, Maso LD, Igbinoba F, et al. Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agent Cancer. 2014;9:1.
67. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol. 2011;40:885-901.
68. Holmes MD, Dalal S, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa. Part II-the case for cohort studies. PLoS Med. 2010;7:e1000244.
69. Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006;118:985-990.
70. Cohen J. HIV/AIDS. Cancer genes help HIV persist, complicating cure efforts. Science. 2014;343:1188.
71. Li CJ, Wang C, Friedman DJ, et al. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 1995;92:5461-5464.
72. Zhou F, Xue M, Qin D, et al. HIV-1 Tat promotes Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-induced angiogenesis and tumor-igenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PLoS One. 2013;8:e53145.
73. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506.
74. Chokunonga E, Borok MZ, Chirenje ZM, et al. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer. 2013;133:721-729.
75. Puvaneswaran B, Shoba B. Misdiagnosis of tuberculosis in patients with lymphoma. S Afr Med J. 2013;103:32-33.
76. Mosam A, Carrara H, Shaik F, et al. Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006). Int J STD AIDS. 2009;20:553-556.
77. Jiang L, Mancuso M, Lu Z, et al. Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Sci Rep. 2014;4: 4137.
78. Krown SE. Cancer in resource-limited settings. J Acquir Immune Defic Syndr. 2011;56:297-299.
79. Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54:670-674.
80. Orem J, Maganda A, Mbidde EK, et al. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer. 2009;52:455-458.
81. Stefan DC, Wessels G, Poole J, et al. Infection with human immunodeficiency virus-1 (HIV) among children with cancer in South Africa. Pediatr Blood Cancer. 2011;56:77-79.
82. World Health Organization. World Health Statistics 2010. Geneva, Switzerland: World Health Organization; 2010.
83. Anonymous. Parliament of the Republic of Kenya. 2011. Available at: http://www.parliament.go.ke. Accessed March 14, 2014.
84. Morhason-Bello IO, Odedina F, Rebbeck TR, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol. 2013; 14:e142-151.
85. Sloan FA, Gelband H. Cancer Control Opportunities in Low-and Middle-Income Countries. Washington, DC: Institute of Medicine of the National Academies, National Academic Press; 2007.
86. Ribeiro RC, Pui CH. Saving the children-improving childhood cancer treatment in developing countries. N Engl J Med. 2005;352:2158-2160.
87. Hopkins J, Burns E, Eden T. International twinning partnerships: an effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries. J Cancer Policy. 2013;1: e8-e19.
88. Feldman MD, Arean PA, Marshall SJ, et al. Does mentoring matter: results from a survey of faculty mentees at a large health sciences university. Med Educ Online. 2010;15:5063.
89. Pololi LH, Krupat E, Civian JT, et al. Why are a quarter of faculty considering leaving academic medicine? A study of their perceptions of institutional culture and intentions to leave at 26 representative U.S. medical schools. Acad Med. 2012;87:859-869.
90. Sambunjak D, Straus SE, Marusic A. Mentoring in academic medicine: a systematic review. JAMA. 2006;296:1103-1115.
91. Nakanjako D, Byakika-Kibwika P, Kintu K, et al. Mentorship needs at academic institutions in resource-limited settings: a survey at Mak-erere University College of Health Sciences. BMC Med Educ. 2011; 11:53.
92. Slone JS, Chunda-Liyoka C, Perez M, et al. Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia. PLoS One. 2014;9:e89102.